Search

Your search keyword '"YAMAGATA, Kunihiro"' showing total 1,583 results

Search Constraints

Start Over You searched for: Author "YAMAGATA, Kunihiro" Remove constraint Author: "YAMAGATA, Kunihiro"
1,583 results on '"YAMAGATA, Kunihiro"'

Search Results

1. Data collaboration for causal inference from limited medical testing and medication data

7. Evaluating the associations between compliance with CKD guideline component metrics and renal outcomes

9. Cigarette smoking and progression of kidney dysfunction: a longitudinal cohort study

12. Symptom Burden and Its Impact on Quality of Life in Patients With Moderate to Severe CKD: The International Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps)

13. The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial

14. Synergistic effect of proteinuria on dipstick hematuria-related decline in kidney function: The Japan Specific Health Checkups (J-SHC) Study

15. Quantification of escape from X chromosome inactivation with single-cell omics data reveals heterogeneity across cell types and tissues

17. Trace proteinuria detected via dipstick test is associated with kidney function decline and new-onset overt proteinuria: the Japan Specific Health Checkups (J-SHC) Study

24. CKD-Associated Pruritus and Clinical Outcomes in Nondialysis CKD

26. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

27. Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS)

30. The efficacy and safety of mizoribine for maintenance therapy in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: the usefulness of serum mizoribine monitoring

31. DOCK2 is involved in the host genetics and biology of severe COVID-19

37. Machine-learning-based identification of patients with IgA nephropathy using a computerized medical billing database.

38. Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease

40. Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study

43. Constipation and risk of death and cardiovascular events.

44. Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease

45. Potential Surrogate Outcomes for Kidney Failure in Advanced CKD: Evaluation of Power and Predictive Ability in CKDopps

47. Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study

49. The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force

Catalog

Books, media, physical & digital resources